Biomeme is a company headquartered in the United States.
Biomeme develops portable molecular diagnostic systems and assays for point-of-care healthcare, biodefense, and wellness. Its products include the Biomeme/5 platform for rapid isothermal amplification and the Franklin ISP portable real-time PCR thermocycler for field-deployable DNA/RNA testing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.